recombinant human Erbb3 fragment therapeutic tumor vaccine(Zensun)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant human Erbb3 fragment therapeutic tumor vaccine(Zensun)
Drug Alias NameniubiaoweitaiRecombinant Human Neu Epitope Peptide 12 (Zensun)rhErbb3-f therapeutic vaccine(Zensun)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesZensun (Shanghai) Sci&Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZensun (Shanghai) Sci&Tech Co Ltd
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A